J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 9,390.00
-740.00 (-7.31%)
At close: May 18, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 54.91 billion as of May 19, 2026. Its market cap has decreased by -19.67% in one year.
Market Cap
54.91B
Enterprise Value
43.34B
Revenue
32.97B
Ranking
n/a
PE Ratio
20.46
Stock Price
9,390.00
Market Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 54.91B, a decrease of -62.11%. That is a compound annual growth rate of -36.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 54.91B | 9.19% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 69.07B |
| Shaperon | 66.91B |
| Quratis | 66.19B |
| Progen | 63.65B |
| EyeGene | 62.64B |
| HLB Pep | 61.34B |
| Psomagen | 59.73B |
| Aptamer Sciences | 51.97B |